z-logo
Premium
Novel transgenic technology reveals several molecular adaptations and potential therapeutic targets in the direct pathway in levodopa‐induced dyskinesia
Author(s) -
Visanji Naomi P.
Publication year - 2014
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.25906
Subject(s) - dyskinesia , levodopa , movement disorders , neuroscience , psychology , disease , parkinson's disease , medicine

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom